KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer

Figure 4

Univariate Cox regression analysis and survival analysis of KNSTRN. (a–d) The forest map displays the pan-cancer univariate Cox regression outcomes of KNSTRN for overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI) in The Cancer Genome Atlas (TCGA). (e–o) Kaplan-Meier analysis of the correlation between the OS of cancer patients and KNSTRN expression by using TCGA database. The median value of KNSTRN expression in each tumor was taken as the cut-off value.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)